Regarding metabolic disorders, our study confirmed that a pre-Tx diagnosis with diabetes mellitus was an independent risk factor along with serum LOXL2 levels; however, the number of patients who were positive for both parameters was too small (N = 5) for evaluation. The gene discussed is LOXL2; the disease is metabolic disease.